Emily M. Geraci, Pharm.D.
Contact
Office
(585) 551-7724
About Me
Education:
Doctor of Pharmacy
Wegmans School of Pharmacy, St. John Fisher University - Rochester, NY
Postgraduate Training:
PGY2 Pediatric Pharmacy Residency Program
University of Rochester Medical Center, Golisano Children's Hospital - Rochester, NY
PGY1 Pharmacy Residency...
Doctor of Pharmacy
Wegmans School of Pharmacy, St. John Fisher University - Rochester, NY
Postgraduate Training:
PGY2 Pediatric Pharmacy Residency Program
University of Rochester Medical Center, Golisano Children's Hospital - Rochester, NY
PGY1 Pharmacy Residency...
Education:
Doctor of Pharmacy
Wegmans School of Pharmacy, St. John Fisher University - Rochester, NY
Postgraduate Training:
PGY2 Pediatric Pharmacy Residency Program
University of Rochester Medical Center, Golisano Children's Hospital - Rochester, NY
PGY1 Pharmacy Residency Program
Penn State Health, Milton S. Hershey Medical Center - Hershey, PA
Professional Experiences:
Clinical Pharmacy Specialist - Neonatal Intensive Care
University of Rochester Medical Center, Golisano Children's Hospital - Rochester, NY
Pediatric Clinical Staff Pharmacist
University of Rochester Medical Center, Golisano Children's Hospital - Rochester, NY
Doctor of Pharmacy
Wegmans School of Pharmacy, St. John Fisher University - Rochester, NY
Postgraduate Training:
PGY2 Pediatric Pharmacy Residency Program
University of Rochester Medical Center, Golisano Children's Hospital - Rochester, NY
PGY1 Pharmacy Residency Program
Penn State Health, Milton S. Hershey Medical Center - Hershey, PA
Professional Experiences:
Clinical Pharmacy Specialist - Neonatal Intensive Care
University of Rochester Medical Center, Golisano Children's Hospital - Rochester, NY
Pediatric Clinical Staff Pharmacist
University of Rochester Medical Center, Golisano Children's Hospital - Rochester, NY
Research
Clinical research interests include: neonatology, neurology, and pediatric critical care.
Publications:
Geraci E, Cake C, Mulieri K, Fenn N. Evaluation of antiemetics in the management of pediatric cannabinoid hyperemesis syndrome. Journal of Pediatric Pharmacotherapy and Therapeutics. 20...
Publications:
Geraci E, Cake C, Mulieri K, Fenn N. Evaluation of antiemetics in the management of pediatric cannabinoid hyperemesis syndrome. Journal of Pediatric Pharmacotherapy and Therapeutics. 20...
Clinical research interests include: neonatology, neurology, and pediatric critical care.
Publications:
Geraci E, Cake C, Mulieri K, Fenn N. Evaluation of antiemetics in the management of pediatric cannabinoid hyperemesis syndrome. Journal of Pediatric Pharmacotherapy and Therapeutics. 2023;28(3):222-227. [10.5863/1551-6776-28.3.222.]
Geraci E, Chablani L. Immunotherapy as a second-line or later treatment modality for advanced non-small cell lung cancer: A review of safety and efficacy. Critical Reviews in Oncology/Hematology. 2020;152: 103009. [doi: 10.1016/j.critrevonc.2020.103009]
Publications:
Geraci E, Cake C, Mulieri K, Fenn N. Evaluation of antiemetics in the management of pediatric cannabinoid hyperemesis syndrome. Journal of Pediatric Pharmacotherapy and Therapeutics. 2023;28(3):222-227. [10.5863/1551-6776-28.3.222.]
Geraci E, Chablani L. Immunotherapy as a second-line or later treatment modality for advanced non-small cell lung cancer: A review of safety and efficacy. Critical Reviews in Oncology/Hematology. 2020;152: 103009. [doi: 10.1016/j.critrevonc.2020.103009]